Last reviewed · How we verify

NCT03918200

Serum Amyloid A in Women With Unexplained Infertility

Completed Last updated 17 April 2019
What this trial tests

trial testing Serum amyloid A level in Infertility in 90 participants. Completed in 10 March 2019.

Timeline
1 October 2018
Primary endpoint
10 March 2019
10 March 2019

Quick facts

Lead sponsorAin Shams Maternity Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment90
Start date1 October 2018
Primary completion10 March 2019
Estimated completion10 March 2019
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Ain Shams Maternity Hospital

Who can join

Under 40, female only, with Infertility. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

High follicular fluid amyloid A level is associated with reduced pregnancy rate. The aim of this study was to find an association between serum level of amyloid A and unexplained infertility.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Infertility

Currently open trials in the same condition.

Other Ain Shams Maternity Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03918200.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing